NZ582284A - Carbamoyl-cyclohexanes for treating acute mania - Google Patents

Carbamoyl-cyclohexanes for treating acute mania

Info

Publication number
NZ582284A
NZ582284A NZ582284A NZ58228408A NZ582284A NZ 582284 A NZ582284 A NZ 582284A NZ 582284 A NZ582284 A NZ 582284A NZ 58228408 A NZ58228408 A NZ 58228408A NZ 582284 A NZ582284 A NZ 582284A
Authority
NZ
New Zealand
Prior art keywords
acute mania
cyclohexanes
carbamoyl
treating acute
effective amount
Prior art date
Application number
NZ582284A
Other languages
English (en)
Inventor
Gyorgy Nemeth
Istvan Laszlovszky
Gyorgy Andor
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Publication of NZ582284A publication Critical patent/NZ582284A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ582284A 2007-05-24 2008-05-19 Carbamoyl-cyclohexanes for treating acute mania NZ582284A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0700370A HUP0700370A2 (en) 2007-05-24 2007-05-24 Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment of acute mania
PCT/HU2008/000052 WO2008142463A2 (en) 2007-05-24 2008-05-19 Carbamoyl-cyclohexanes for treating acute mania

Publications (1)

Publication Number Publication Date
NZ582284A true NZ582284A (en) 2012-07-27

Family

ID=89987541

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ582284A NZ582284A (en) 2007-05-24 2008-05-19 Carbamoyl-cyclohexanes for treating acute mania

Country Status (26)

Country Link
US (1) US20100197704A1 (OSRAM)
EP (1) EP2164572B2 (OSRAM)
JP (1) JP2010527985A (OSRAM)
KR (1) KR20150076266A (OSRAM)
CN (2) CN101678212A (OSRAM)
AU (1) AU2008252621B2 (OSRAM)
CA (1) CA2687528C (OSRAM)
CY (1) CY1113566T1 (OSRAM)
DK (1) DK2164572T4 (OSRAM)
EA (1) EA021936B1 (OSRAM)
ES (1) ES2397962T5 (OSRAM)
GE (1) GEP20135731B (OSRAM)
HR (1) HRP20130092T4 (OSRAM)
HU (1) HUP0700370A2 (OSRAM)
IL (1) IL202048A (OSRAM)
MX (1) MX2009012752A (OSRAM)
MY (1) MY148955A (OSRAM)
NZ (1) NZ582284A (OSRAM)
PL (1) PL2164572T5 (OSRAM)
PT (1) PT2164572E (OSRAM)
RS (1) RS52613B2 (OSRAM)
SI (1) SI2164572T2 (OSRAM)
TW (1) TWI428130B (OSRAM)
UA (1) UA101323C2 (OSRAM)
WO (1) WO2008142463A2 (OSRAM)
ZA (1) ZA200908283B (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0700353A2 (en) * 2007-05-18 2008-12-29 Richter Gedeon Nyrt Metabolites of (thio)carbamoyl-cyclohexane derivatives
US7875610B2 (en) * 2007-12-03 2011-01-25 Richter Gedeon Nyrt. Pyrimidinyl-piperazines useful as D3/D2 receptor ligands
CN102014909B (zh) * 2008-02-21 2013-03-13 田边三菱制药株式会社 口服用固体制剂
RS53866B1 (sr) 2008-07-16 2015-08-31 Richter Gedeon Nyrt. Farmaceutske formulacije koje sadrže ligande dopaminskih receptora
HU230067B1 (hu) 2008-12-17 2015-06-29 Richter Gedeon Nyrt Új piperazin só és eljárás előállítására
HUP0800765A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Nyrt A new process for the preparation of piperazine derivatives and their hydrochloric salts
HUP0800766A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Vegyeszet Process for the preparation of piperazine derivatives
US9610274B2 (en) * 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
US8912197B2 (en) 2012-08-20 2014-12-16 Forest Laboratories Holdings Ltd. Crystalline form of carbamoyl-cyclohexane derivatives
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1250214C (zh) * 2001-02-27 2006-04-12 奥索-麦克尼尔药品公司 用于预防或治疗双相性精神障碍的氨基甲酸酯化合物
HU227534B1 (en) * 2003-08-04 2011-08-29 Richter Gedeon Nyrt (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them
KR20100027137A (ko) * 2007-05-11 2010-03-10 리히터 게데온 닐트. 카르바모일-사이클로헥산 유도체의 신규한 용매화물 및 결정 형태

Also Published As

Publication number Publication date
US20100197704A1 (en) 2010-08-05
MY148955A (en) 2013-06-14
SI2164572T2 (sl) 2016-01-29
ZA200908283B (en) 2010-08-25
HUP0700370A2 (en) 2009-04-28
JP2010527985A (ja) 2010-08-19
IL202048A0 (en) 2010-06-16
DK2164572T4 (en) 2016-01-04
KR20150076266A (ko) 2015-07-06
TW201002326A (en) 2010-01-16
CA2687528C (en) 2016-07-05
MX2009012752A (es) 2010-03-15
PT2164572E (pt) 2013-01-28
RS52613B (sr) 2013-04-30
UA101323C2 (en) 2013-03-25
HK1136984A1 (en) 2010-07-16
EA021936B1 (ru) 2015-10-30
AU2008252621B2 (en) 2013-09-19
EP2164572B1 (en) 2012-11-14
CN105193807A (zh) 2015-12-30
EP2164572B2 (en) 2015-09-16
CA2687528A1 (en) 2008-11-27
PL2164572T3 (pl) 2013-04-30
HRP20130092T1 (en) 2013-02-28
EP2164572A2 (en) 2010-03-24
CY1113566T1 (el) 2016-06-22
HU0700370D0 (en) 2007-07-30
DK2164572T3 (da) 2013-02-11
PL2164572T5 (pl) 2016-02-29
AU2008252621A1 (en) 2008-11-27
ES2397962T5 (es) 2016-01-08
CN101678212A (zh) 2010-03-24
SI2164572T1 (sl) 2013-02-28
IL202048A (en) 2014-11-30
EA200971087A1 (ru) 2010-04-30
WO2008142463A2 (en) 2008-11-27
HRP20130092T4 (hr) 2016-01-01
GEP20135731B (en) 2013-01-25
ES2397962T3 (es) 2013-03-12
RS52613B2 (sr) 2018-05-31
TWI428130B (zh) 2014-03-01
WO2008142463A3 (en) 2009-03-05

Similar Documents

Publication Publication Date Title
NZ582284A (en) Carbamoyl-cyclohexanes for treating acute mania
EA201391705A1 (ru) Триазолпиридиновые ингибиторы 11-бета-гидроксистероиддегидрогеназы типа i
MY156243A (en) Treatment for diabetes in patients inappropriate for metformin therapy
EP4424328A3 (en) Treatment of hidradenitis suppurativa using jak inhibitors
IL200956A0 (en) 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition
HRP20120144T1 (en) Therapeutic uses of compounds having combined sert, 5-ht3 and 5-ht1a activity
EA201070121A1 (ru) Лекарственная форма, содержащая слитый белок glp-1-fc
IL192181A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
NZ611654A (en) Treatment of jak2-mediated conditions
DE502004005033D1 (de) Substituierte 2-aminotetraline zur behandlung von depressionen
PL2164492T3 (pl) Trans-4-{2-[4-(2,3-dichlorofenylo)-piperazyn 1-ylo]-etylo}-N,Ndimetylokarbamoilocykloheksylamina do leczenia schizofrenii
MX2020008086A (es) Metodos y composiciones para tratar la apnea del sue?o.
NZ590839A (en) Treatment of pulmonary arterial hypertension
AR077139A1 (es) Composiciones farmaceuticas utiles para tratar el vch
EA201100872A1 (ru) Производные хиназолинамида
MY139498A (en) Composition, process of making, and medical use of substituted 4-phenyltetrahydroisoquinolines
TN2009000357A1 (en) ACID ADDITION SALTS, HYDRATES AND POLYMORPHS OF 5¬(2,4-DIHYDROXY-5- ISOPROPYL-PHENYL)- 4- (4-MORPHOLIN -4¬YLMETHYL-PHENYL) - ISOXAZOLE-3-CARBOXYLlC ACID ETHYLAMIDE AND FORMULATIONS COMPRISING THESE FORMS
TNSN08506A1 (en) Substituted carboxamides
MX2009004770A (es) Compuestos de carbamato para usarse en el tratamiento de la depresion.
TN2010000266A1 (en) Oxazolidinones for the treatment and/or prophylaxis of heart failure
TNSN07364A1 (en) Use of agomelatine for obtaining medicaments used for treating bipolar disorders
TN2010000249A1 (en) New medical use of 3-(2,2,2-trimethylhydrazinium ) propionate salts
NZ593282A (en) Ethanamine compounds and their use for treating depression
WO2006086978A3 (de) Verwendung deuterierter n-[2-(5-methoxy-1h-indol-3-yl)-ethyl]acetamide und deren pharmazeutisch verträglicher salze sowie diese verbindungen enthaltende arzneimittel
CA2706354A1 (en) Use of hydrogen fumarate and dihydrogen phosphate salts of meldonium in treating or preventing atherosclerosis

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 19 MAY 2015 BY DENNEMEYER + CO

Effective date: 20130119

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 19 MAY 2018 BY DENNEMEYER + CO

Effective date: 20140822

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 MAY 2019 BY DENNEMEYER + CO

Effective date: 20180423

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 MAY 2020 BY DENNEMEYER + CO.

Effective date: 20190419

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 MAY 2021 BY PETRA OLK

Effective date: 20200511

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 MAY 2022 BY DENNEMEYER + CO.

Effective date: 20210510

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 MAY 2023 BY DENNEMEYER + CO. S.A.R.L.

Effective date: 20220509

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 MAY 2024 BY DENNEMEYER + CO. S.A.R.L.

Effective date: 20230508

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 MAY 2025 BY DENNEMEYER + CO.

Effective date: 20240506

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 MAY 2026 BY DENNEMEYER + CO. SARL

Effective date: 20250513